We are live on ! Find out more
WX

WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX

Delisted

WX was delisted on the 10th of December, 2015.

Back to rankings

Fund managers haven’t disclosed any holdings of WX yet.

WX Hedge Fund Activity: Q2 2016 in Review

0 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q2 2016, worth a combined $0 — down 100% from $182K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of WX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Huntington National Bank, exiting entirely with an estimated $182K sold.

  • 0 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q2 2016, down from 1 in Q1 2016.
  • Funds reported $0 of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q2 2016, down 100% quarter-over-quarter.
  • 0 funds opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q2 2016 and 1 closed out, a net change of -1 holder.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q2 2016 was Huntington National Bank, an estimated $182K sold.

Based on aggregated 13F filings for Q2 2016.